Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 6—June 2014

MERS Coronaviruses in Dromedary Camels, Egypt

Daniel K.W. Chu1, Leo L.M. Poon1, Mokhtar M. Gomaa, Mahmoud M. Shehata, Ranawaka A.P.M. Perera, Dina Abu Zeid, Amira S. El Rifay, Lewis Y. Siu, Yi Guan, Richard J. Webby, Mohamed A. Ali, Malik PeirisComments to Author , and Ghazi KayaliComments to Author 
Author affiliations: The University of Hong Kong, Hong Kong, China (D.K.W. Chu, L.L.M. Poon, R.A.P.M. Perera, Y. Guan, M. Peiris); National Research Centre, Giza, Egypt (M.M. Gomaa, M.M. Shehata, D.A. Zeid, A.S. El Rifay, M.A. Ali); HKU-Pasteur Research Pole, Hong Kong (L.Y. Siu); St. Jude Children’s Research Hospital, Memphis, Tennessee, USA (R.J. Webby, G. Kayali)

Main Article

Table 2

Percentage identity between ORFs of dromedary camel MERS-CoV (NRCE-HKU205) and human MERS-CoV (EMC/2012) at the nucleotide and amino acid levels*

ORF % Identity to HCoV-EMC/2012
Nucleotide Amino acid
ORF1a 99.5 99.2
ORF1b 99.5 99.7
S 99.2 98.9
ORF3 99.0 98.0
ORF4a 99.0 100
ORF4b 99.4 99.1
ORF5 99.4 98.6
E 100 100
M 100 100
N 99.4 99.2
ORF8b 99.1 98.2

*ORF, open reading frame; MERS, Middle East respiratory syndrome; CoV, coronavirus; H, human; E, envelope; M, membrane; N, nucleocapsid.

Main Article

1These authors contributed equally to this article.

Page created: May 16, 2014
Page updated: May 16, 2014
Page reviewed: May 16, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.